LONDON--(BUSINESS WIRE)--High incidence of chronic diseases globally and the need for personalized medicine, has encouraged several technological advancements in the form of recombinant DNA that involves genetic combinations of species to treat diseases. The recombinant DNA technology increases the demand for molecular biology enzymes, kits, and reagents as they are required for successful recombinant protein expression and cell extraction. These factors will positively impact market growth during the forecast period. Furthermore, this industry research report also presents a competitive analysis of the market by end user (biotechnology and pharmaceutical companies, hospitals and diagnostic centers, and academic institutes and research organizations) and geography (Asia, Europe, North America, and ROW).
Competitive vendor landscape
The global molecular biology enzymes, kits, and reagents market is highly competitive with major vendors such as Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd, Illumina, Inc., Merck KGaA, and Thermo Fisher Scientific Inc., competing based on price, quality, and product/service offerings.
“To gain higher market shares, companies as a key strategy are involved in acquisitions and partnerships along with effective product launches. Leading corporations are aggressively pursuing to enhance their capabilities to gain a competitive edge through joint ventures, MoUs, and agreements or acquisitions,” says a senior analyst at Technavio.
Top five molecular biology enzymes, kits, and reagents market vendors
Agilent Technologies, Inc.
Agilent Technologies, Inc. operates in three segments: life sciences and applied markets; diagnostics and genomics; and Agilent crosslab. The company’s key offerings include Cloning Kits, PCR Inhibitors, and PCR-Based Specialty Kits & Reagents.
F. Hoffmann-La Roche Ltd
F. Hoffmann-La Roche Ltd runs its operations through two segments: diagnostics and pharmaceuticals. The company’s key offerings include: High Pure Viral Nucleic Acid Buffer Set, High Pure FFPET RNA Isolation Kit, and High Pure Viral RNA Kit.
Illumina, Inc.
Illumina, Inc. runs its operations through two segments: Core Illumina and Consolidated VIEs. The company’s key offerings include Infinium FFPE QC and DNA Restoration Kits, and TruSeq Custom Amplicon Low Input Kit.
Merck KGaA
Merck KGaA runs its operations through three segments: healthcare, life science, and performance materials. The company’s key offerings include: Modifying Enzymes, Restriction Enzymes, and Ultra Pure Modifying Enzymes.
Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. runs its operations through four segments: life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and services. The company’s key offerings include: FastDigest Restriction Enzymes, DreamTaq DNA Polymerases, and CloneJET PCR Cloning Kit.
Looking for more information on this market? Request a free sample report
Technavio’s sample reports are free of charge and contain multiple sections of the report, including the market size and forecast, drivers, challenges, trends, and more.
Browse Related Reports:
- Global Influenza Diagnostics Market 2019-2023 - The market research study identifies Abbott Laboratories, bioMérieux SA, Bio-Rad Laboratories Inc., Danaher Corp., and Thermo Fisher Scientific Inc., as the leading players in the global influenza diagnostics market.
- Global Fecal Occult Testing Market 2019-2023 - The market research study identifies Abbott Laboratories, bioMérieux SA, Danaher Corp., Eiken Chemical Co. Ltd., and Quidel Corp., as the leading players in the global fecal occult testing market.
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at media@technavio.com.
